Brigham and Women's Hospital: Atherosclerosis trials

The registry lists 13 Atherosclerosis studies with Brigham and Women's Hospital as lead sponsor. 1 are open to participants now and 4 have results posted.

Phase 2 3Phase 3 3Phase 4 1No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) StudyRecruitingNCT07315997
• The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET ScanTerminatedNCT01238588Not applicableResults posted
• Novel Pathways to Manage Inflammation and Atherosclerosis in Dialysis Patients: Role of Nicotinic AcidTerminatedNCT01159054Not applicableResults posted
• Inflammation and Vascular Function in AtherosclerosisCompletedNCT00760019Phase 2/3Results posted
• Testosterone Replacement in Older Men and Atherosclerosis ProgressionCompletedNCT00287586Phase 4Results posted
• Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)CompletedNCT07203677
• Prediction of Progression of Coronary Artery Disease (CAD) Using Vascular Profiling of Shear Stress and Wall MorphologyStatus unknownNCT01316159
• The Effect of Fasudil on Vascular Function in HumansCompletedNCT00120718Phase 2
• Rho Kinase in Patients With AtherosclerosisCompletedNCT00115830Phase 3
• The Effects of Atorvastatin in Patients With AtherosclerosisCompletedNCT00115817Phase 3
• The Contribution of Endothelin to Vasomotor Function in Diseased Coronary ArteriesCompletedNCT00115583Not applicable
• Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)CompletedNCT00054938Phase 2
• Dyslipidemia and Risk of Cardiovascular Disease in Diabetic Men and WomenCompletedNCT00037258